JP2011526785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526785A5 JP2011526785A5 JP2011516790A JP2011516790A JP2011526785A5 JP 2011526785 A5 JP2011526785 A5 JP 2011526785A5 JP 2011516790 A JP2011516790 A JP 2011516790A JP 2011516790 A JP2011516790 A JP 2011516790A JP 2011526785 A5 JP2011526785 A5 JP 2011526785A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- seq
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7704108P | 2008-06-30 | 2008-06-30 | |
| US61/077,041 | 2008-06-30 | ||
| US9703408P | 2008-09-15 | 2008-09-15 | |
| US61/097,034 | 2008-09-15 | ||
| PCT/US2009/049139 WO2010002822A1 (en) | 2008-06-30 | 2009-06-30 | Anti-gd2 antibodies and methods and uses related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011526785A JP2011526785A (ja) | 2011-10-20 |
| JP2011526785A5 true JP2011526785A5 (https=) | 2012-08-16 |
| JP5654986B2 JP5654986B2 (ja) | 2015-01-14 |
Family
ID=41139062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011516790A Expired - Fee Related JP5654986B2 (ja) | 2008-06-30 | 2009-06-30 | 抗ｇｄ２抗体並びにそれに関連する方法及び使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8278065B2 (https=) |
| EP (1) | EP2310416A1 (https=) |
| JP (1) | JP5654986B2 (https=) |
| KR (1) | KR20110025859A (https=) |
| CN (1) | CN102164962B (https=) |
| AU (1) | AU2009267113A1 (https=) |
| CA (1) | CA2729499A1 (https=) |
| IL (1) | IL210147A0 (https=) |
| MX (1) | MX2010014364A (https=) |
| TW (1) | TWI466684B (https=) |
| WO (1) | WO2010002822A1 (https=) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8278065B2 (en) | 2008-06-30 | 2012-10-02 | Morphotek, Inc. | Polynucleotides encoding anti-GD2 antibodies |
| WO2013189516A1 (en) | 2012-06-18 | 2013-12-27 | Apeiron Biologics Ag | Method for treating a gd2 positive cancer |
| WO2014083006A1 (en) * | 2012-11-30 | 2014-06-05 | Katinger Gmbh | RECOMBINANT HUMAN IgM-ANTIBODY EFFECTIVE AGAINST CANCER CELLS |
| TWI707038B (zh) | 2013-08-05 | 2020-10-11 | 美商扭轉生物科技有限公司 | 重新合成之基因庫 |
| JPWO2015019821A1 (ja) * | 2013-08-05 | 2017-03-02 | ソニー株式会社 | 情報処理装置、情報処理方法及びコンピュータプログラム |
| US9840566B2 (en) | 2013-11-21 | 2017-12-12 | Apeiron Biologics Ag | Preparations and methods for treating a GD2 positive cancer |
| DK3071220T3 (da) | 2013-11-21 | 2020-02-10 | Apeiron Biologics Ag | Præparater til at behandle en gd2-positiv cancer |
| CA2971151C (en) * | 2014-01-09 | 2020-10-27 | Kentucky Bioprocessing, Inc. | Method of purifying monoclonal antibodies |
| SG11201605580RA (en) | 2014-01-10 | 2016-10-28 | Anaptysbio Inc | Antibodies directed against interleukin-33 (il-33) |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US10294306B2 (en) * | 2015-05-28 | 2019-05-21 | Bio-Rad Laboratories, Inc. | Affinity ligands and methods relating thereto |
| KR20180050411A (ko) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | 올리고핵산 변이체 라이브러리 및 그의 합성 |
| KR102794025B1 (ko) | 2015-09-22 | 2025-04-09 | 트위스트 바이오사이언스 코포레이션 | 핵산 합성을 위한 가요성 기판 |
| DK3368571T5 (da) | 2015-10-30 | 2024-09-30 | Univ California | Transformerende, vækstfaktor-beta-responsive polypeptider og fremgangsmåder til anvendelse deraf |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| CN110892485B (zh) | 2017-02-22 | 2024-03-22 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| US10696965B2 (en) | 2017-06-12 | 2020-06-30 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| CN111566125A (zh) | 2017-09-11 | 2020-08-21 | 特韦斯特生物科学公司 | Gpcr结合蛋白及其合成 |
| CN111565834B (zh) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | 用于多核苷酸合成的加热的纳米孔 |
| KR102804057B1 (ko) | 2018-01-04 | 2025-05-07 | 트위스트 바이오사이언스 코포레이션 | Dna 기반 디지털 정보 저장 |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| US12357959B2 (en) | 2018-12-26 | 2025-07-15 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| CN113766930B (zh) | 2019-02-26 | 2025-07-22 | 特韦斯特生物科学公司 | Glp1受体的变异核酸文库 |
| CA3131691A1 (en) | 2019-02-26 | 2020-09-03 | Twist Bioscience Corporation | Variant nucleic acid libraries for antibody optimization |
| JP2022532766A (ja) | 2019-05-17 | 2022-07-19 | キャンサー プリベンション ファーマシューティカルズ，インコーポレイテッド | 家族性腺腫性ポリポーシスを処置するための方法 |
| CA3142000A1 (en) | 2019-06-19 | 2020-12-24 | Icahn School Of Medicine At Mount Sinai | Monoclonal antibodies against jc virus |
| AU2020298294A1 (en) | 2019-06-21 | 2022-02-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| US20220275104A1 (en) * | 2019-08-01 | 2022-09-01 | Mie University | Gd2 binding molecule |
| WO2021061842A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| JP2022548309A (ja) | 2019-09-23 | 2022-11-17 | ツイスト バイオサイエンス コーポレーション | Ｃｒｔｈ２のバリアント核酸ライブラリー |
| IL293670A (en) | 2019-12-09 | 2022-08-01 | Twist Bioscience Corp | Variable nucleic acid libraries for adenosine receptors |
| CN114685658B (zh) * | 2020-12-30 | 2024-12-17 | 百力司康生物医药(杭州)有限公司 | Ox40的靶向抗体及其制备方法和应用 |
| WO2022159620A1 (en) | 2021-01-21 | 2022-07-28 | Twist Bioscience Corporation | Methods and compositions relating to adenosine receptors |
| TW202302648A (zh) * | 2021-03-12 | 2023-01-16 | 美商健生生物科技公司 | Cd79b抗體於自體免疫治療應用之用途 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025076127A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5419904A (en) * | 1990-11-05 | 1995-05-30 | The Regents Of The University Of California | Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
| WO1993010221A1 (en) | 1991-11-13 | 1993-05-27 | The Regents Of The University Of California | Chimeric murine/human anti-idiotype monoclonal antibodies |
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| WO1997034634A1 (en) * | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Single chain fv constructs of anti-ganglioside gd2 antibodies |
| AU725329B2 (en) * | 1996-09-02 | 2000-10-12 | Ko Okumura | Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand |
| CN100432105C (zh) * | 2002-12-17 | 2008-11-12 | 默克专利有限公司 | 与gd2结合的小鼠14.18抗体的人源化抗体(h14.18)以及其与il-2的融合 |
| ATE490787T1 (de) * | 2003-07-15 | 2010-12-15 | Chugai Pharmaceutical Co Ltd | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion |
| FR2906808B1 (fr) * | 2006-10-10 | 2012-10-05 | Univ Nantes | Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers |
| US8278065B2 (en) | 2008-06-30 | 2012-10-02 | Morphotek, Inc. | Polynucleotides encoding anti-GD2 antibodies |
-
2009
- 2009-06-30 US US12/494,631 patent/US8278065B2/en not_active Expired - Fee Related
- 2009-06-30 CN CN200980132087.5A patent/CN102164962B/zh not_active Expired - Fee Related
- 2009-06-30 EP EP09774273A patent/EP2310416A1/en not_active Withdrawn
- 2009-06-30 CA CA2729499A patent/CA2729499A1/en not_active Abandoned
- 2009-06-30 MX MX2010014364A patent/MX2010014364A/es active IP Right Grant
- 2009-06-30 KR KR1020117002248A patent/KR20110025859A/ko not_active Withdrawn
- 2009-06-30 JP JP2011516790A patent/JP5654986B2/ja not_active Expired - Fee Related
- 2009-06-30 WO PCT/US2009/049139 patent/WO2010002822A1/en not_active Ceased
- 2009-06-30 TW TW98122129A patent/TWI466684B/zh not_active IP Right Cessation
- 2009-06-30 AU AU2009267113A patent/AU2009267113A1/en not_active Abandoned
-
2010
- 2010-12-21 IL IL210147A patent/IL210147A0/en unknown
-
2012
- 2012-08-23 US US13/593,057 patent/US8507657B2/en not_active Expired - Fee Related
-
2013
- 2013-07-02 US US13/933,594 patent/US8956832B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526785A5 (https=) | ||
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2021524267A5 (https=) | ||
| CN110914304B (zh) | Cd96抗体、其抗原结合片段及医药用途 | |
| JP2014526898A5 (https=) | ||
| RU2014131317A (ru) | Связывающие mica агенты | |
| TW201708261A (zh) | Ｄｌｌ３及ｃｄ３抗體構築體 | |
| WO2015032906A4 (en) | Cd70-binding peptides and method, process and use relating thereto | |
| TW201915026A (zh) | Ｔｉｇｉｔ抗體、其抗原結合片段及醫藥用途 | |
| NZ610734A (en) | Human antibodies to the glucagon receptor | |
| FI3592769T3 (fi) | Vasta-aineita PD-L1:tä vastaan | |
| JP2014534242A5 (https=) | ||
| FI3922645T3 (fi) | Pro-/latentin myostatiinin vasta-aineita ja niiden käyttötapoja | |
| IL290591B1 (en) | Antibody drug conjugates (adc) that bind to 191p4d12 proteins | |
| JP2018527919A5 (https=) | ||
| JP2019534892A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2012509881A5 (https=) | ||
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof | |
| NZ597067A (en) | Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer | |
| JP2011509245A5 (https=) | ||
| JP2011510654A5 (https=) | ||
| JP2014524733A5 (https=) | ||
| JP2010533498A5 (https=) | ||
| FI3322727T3 (fi) | Humanisoituja tai kimeerisiä CD3-vasta-aineita |